Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
[Physician's responsibility in advising about costs].

Die Medizinische Welt

Händel K.
PMID: 6645921
Med Welt. 1983 Nov 04;34(44):1260-1.

No abstract available.

Cite
Händel K. Wirtschaftliche Beratungspflicht. [Physician's responsibility in advising about costs]. Med Welt. 1983;34(44):1260-1
Händel, K. (1983). Wirtschaftliche Beratungspflicht. [Physician's responsibility in advising about costs]. Die Medizinische Welt, 34(44), 1260-1.
Händel, K. "Wirtschaftliche Beratungspflicht." [Physician's responsibility in advising about costs]. Die Medizinische Welt vol. 34,44 (1983): 1260-1.
Händel K. Wirtschaftliche Beratungspflicht. [Physician's responsibility in advising about costs]. Med Welt. 1983 Nov 04;34(44):1260-1. German. PMID: 6645921.
Copy Download .nbib Format: NLM
[Revision of the medical malpractice law--legal aspects].

Zeitschrift fur arztliche Fortbildung und Qualitatssicherung

Schreiber HL.
PMID: 9885162
Z Arztl Fortbild Qualitatssich. 1998 Oct;92(8):568-74.

Since the beginning of this century, modifications of the criminal law regarding medicine have been outlined frequently. The focus of these modifications was to eliminate the circumstance that each medical procedure is a criminal offense even if it was...

Cite
Schreiber HL. Novellierung des Arztstrafrechts--Juristische Gründe. [Revision of the medical malpractice law--legal aspects]. Z Arztl Fortbild Qualitatssich. 1998;92(8):568-74
Schreiber, H. L. (1998). Novellierung des Arztstrafrechts--Juristische Gründe. [Revision of the medical malpractice law--legal aspects]. Zeitschrift fur arztliche Fortbildung und Qualitatssicherung, 92(8), 568-74.
Schreiber, H L. "Novellierung des Arztstrafrechts--Juristische Gründe." [Revision of the medical malpractice law--legal aspects]. Zeitschrift fur arztliche Fortbildung und Qualitatssicherung vol. 92,8 (1998): 568-74.
Schreiber HL. Novellierung des Arztstrafrechts--Juristische Gründe. [Revision of the medical malpractice law--legal aspects]. Z Arztl Fortbild Qualitatssich. 1998 Oct;92(8):568-74. German. PMID: 9885162.
Copy Download .nbib Format: NLM
[Equal access to patient education in oncology in France: Myth or reality?].

Bulletin du cancer

Huteau ME, Berger V, Hureau M, Boucher S, Stoebner-Delbarre A.
PMID: 31604570
Bull Cancer. 2019 Dec;106(12):1196-1198. doi: 10.1016/j.bulcan.2019.08.015. Epub 2019 Oct 08.

No abstract available.

Cite
Huteau ME, Berger V, Hureau M, et al. Égal accès aux soins éducatifs en cancérologie en France : mythe ou réalité ? [Equal access to patient education in oncology in France: Myth or reality?]. Bull Cancer. 2019;106(12):1196-1198doi: 10.1016/j.bulcan.2019.08.015.
Huteau, M. E., Berger, V., Hureau, M., Boucher, S., & Stoebner-Delbarre, A. (2019). Égal accès aux soins éducatifs en cancérologie en France : mythe ou réalité ? [Equal access to patient education in oncology in France: Myth or reality?]. Bulletin du cancer, 106(12), 1196-1198. https://doi.org/10.1016/j.bulcan.2019.08.015
Huteau, Marie-Eve, et al. "Égal accès aux soins éducatifs en cancérologie en France : mythe ou réalité ?" [Equal access to patient education in oncology in France: Myth or reality?]. Bulletin du cancer vol. 106,12 (2019): 1196-1198. doi: https://doi.org/10.1016/j.bulcan.2019.08.015
Huteau ME, Berger V, Hureau M, Boucher S, Stoebner-Delbarre A. Égal accès aux soins éducatifs en cancérologie en France : mythe ou réalité ? [Equal access to patient education in oncology in France: Myth or reality?]. Bull Cancer. 2019 Dec;106(12):1196-1198. doi: 10.1016/j.bulcan.2019.08.015. Epub 2019 Oct 08. French. PMID: 31604570.
Copy Download .nbib Format: NLM
[Patient education: regarding risks and adverse reactions].

Deutsche medizinische Wochenschrift (1946)

Ospelt N.
PMID: 27097383
Dtsch Med Wochenschr. 2016 Jan;141(1):64-5.

No abstract available.

Cite
Ospelt N. Patientenaufklärung: Zu Risiken und Nebenwirkungen. [Patient education: regarding risks and adverse reactions]. Dtsch Med Wochenschr. 2016;141(1):64-5
Ospelt, N. (2016). Patientenaufklärung: Zu Risiken und Nebenwirkungen. [Patient education: regarding risks and adverse reactions]. Deutsche medizinische Wochenschrift (1946), 141(1), 64-5.
Ospelt, Nina. "Patientenaufklärung: Zu Risiken und Nebenwirkungen." [Patient education: regarding risks and adverse reactions]. Deutsche medizinische Wochenschrift (1946) vol. 141,1 (2016): 64-5.
Ospelt N. Patientenaufklärung: Zu Risiken und Nebenwirkungen. [Patient education: regarding risks and adverse reactions]. Dtsch Med Wochenschr. 2016 Jan;141(1):64-5. German. PMID: 27097383.
Copy Download .nbib Format: NLM
Stopping HIV before it begins: issues faced by women in India.

Nature immunology

Solomon S, Buck J, Chaguturu SK, Ganesh AK, Kumarasamy N.
PMID: 12888788
Nat Immunol. 2003 Aug;4(8):719-21. doi: 10.1038/ni0803-719.

Despite advances in understanding HIV pathogenesis, the economic, social and legal constraints in India continue to make women particularly vulnerable to HIV infection.

Cite
Solomon S, Buck J, Chaguturu SK, et al. Stopping HIV before it begins: issues faced by women in India. Nat Immunol. 2003;4(8):719-21doi: 10.1038/ni0803-719.
Solomon, S., Buck, J., Chaguturu, S. K., Ganesh, A. K., & Kumarasamy, N. (2003). Stopping HIV before it begins: issues faced by women in India. Nature immunology, 4(8), 719-21. https://doi.org/10.1038/ni0803-719
Solomon, Suniti, et al. "Stopping HIV before it begins: issues faced by women in India." Nature immunology vol. 4,8 (2003): 719-21. doi: https://doi.org/10.1038/ni0803-719
Solomon S, Buck J, Chaguturu SK, Ganesh AK, Kumarasamy N. Stopping HIV before it begins: issues faced by women in India. Nat Immunol. 2003 Aug;4(8):719-21. doi: 10.1038/ni0803-719. PMID: 12888788.
Copy Download .nbib Format: NLM
[Information for the patient. 1/2 the contribution of the law dated March 4, 2202].

Presse medicale (Paris, France : 1983)

Boyer L, Debensason D, Antoniotti S, Giusiano B, Auquier P, Manuel C.
PMID: 14576591
Presse Med. 2003 Oct 11;32(33):1541-4.

No abstract available.

Cite
Boyer L, Debensason D, Antoniotti S, et al. Information du patient. L'apport de la loi du 4 mars 2002. [Information for the patient. 1/2 the contribution of the law dated March 4, 2202]. Presse Med. 2003;32(33):1541-4
Boyer, L., Debensason, D., Antoniotti, S., Giusiano, B., Auquier, P., & Manuel, C. (2003). Information du patient. L'apport de la loi du 4 mars 2002. [Information for the patient. 1/2 the contribution of the law dated March 4, 2202]. Presse medicale (Paris, France : 1983), 32(33), 1541-4.
Boyer, Laurent, et al. "Information du patient. L'apport de la loi du 4 mars 2002." [Information for the patient. 1/2 the contribution of the law dated March 4, 2202]. Presse medicale (Paris, France : 1983) vol. 32,33 (2003): 1541-4.
Boyer L, Debensason D, Antoniotti S, Giusiano B, Auquier P, Manuel C. Information du patient. L'apport de la loi du 4 mars 2002. [Information for the patient. 1/2 the contribution of the law dated March 4, 2202]. Presse Med. 2003 Oct 11;32(33):1541-4. French. PMID: 14576591.
Copy Download .nbib Format: NLM
[Responsibility for patient education in trials of new procedures in humans from the physician's viewpoint].

Zeitschrift fur arztliche Fortbildung

Schneider V.
PMID: 7716981
Z Arztl Fortbild (Jena). 1994 Dec;88(12):1045-50; discussion 1050-4.

No abstract available.

Cite
Schneider V. Aufklärungspflicht bei Erprobung neuer Verfahren am Menschen aus ärztlicher Sicht. [Responsibility for patient education in trials of new procedures in humans from the physician's viewpoint]. Z Arztl Fortbild (Jena). 1994;88(12):1045-50; discussion 1050-4
Schneider, V. (1994). Aufklärungspflicht bei Erprobung neuer Verfahren am Menschen aus ärztlicher Sicht. [Responsibility for patient education in trials of new procedures in humans from the physician's viewpoint]. Zeitschrift fur arztliche Fortbildung, 88(12), 1045-50; discussion 1050-4.
Schneider, V. "Aufklärungspflicht bei Erprobung neuer Verfahren am Menschen aus ärztlicher Sicht." [Responsibility for patient education in trials of new procedures in humans from the physician's viewpoint]. Zeitschrift fur arztliche Fortbildung vol. 88,12 (1994): 1045-50; discussion 1050-4.
Schneider V. Aufklärungspflicht bei Erprobung neuer Verfahren am Menschen aus ärztlicher Sicht. [Responsibility for patient education in trials of new procedures in humans from the physician's viewpoint]. Z Arztl Fortbild (Jena). 1994 Dec;88(12):1045-50; discussion 1050-4. German. PMID: 7716981.
Copy Download .nbib Format: NLM
[Written information prior to interventions].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Gulbrandsen P, Førde R, Kristvik E.
PMID: 20835278
Tidsskr Nor Laegeforen. 2010 Sep 09;130(17):1705. doi: 10.4045/tidsskr.10.0483.

No abstract available.

Cite
Gulbrandsen P, Førde R, Kristvik E. Informasjonsskriv før inngrep. [Written information prior to interventions]. Tidsskr Nor Laegeforen. 2010;130(17):1705doi: 10.4045/tidsskr.10.0483.
Gulbrandsen, P., Førde, R., & Kristvik, E. (2010). Informasjonsskriv før inngrep. [Written information prior to interventions]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 130(17), 1705. https://doi.org/10.4045/tidsskr.10.0483
Gulbrandsen, Pål, et al. "Informasjonsskriv før inngrep." [Written information prior to interventions]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke vol. 130,17 (2010): 1705. doi: https://doi.org/10.4045/tidsskr.10.0483
Gulbrandsen P, Førde R, Kristvik E. Informasjonsskriv før inngrep. [Written information prior to interventions]. Tidsskr Nor Laegeforen. 2010 Sep 09;130(17):1705. doi: 10.4045/tidsskr.10.0483. Norwegian. PMID: 20835278.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries